查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1515603

癌症恶病质市场，按治疗方法、作用机制、应用、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Cancer Cachexia Market, By Therapeutics, By Mechanism of Action, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 288 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023年癌症恶病质市场规模为32.2832亿美元，2024年至2032年复合年增长率为5.90%。

癌症恶病质市场-市场动态

癌症负担上升推动市场需求

全球癌症负担正在上升，需要根据国家和地区的优先事项修改癌症治疗方法。根据国际癌症研究机构 (IARC) 2020 年 12 月的数据，全球五分之一的人会在一生中罹患癌症，其中十分之一的女性和八分之一的男性死于该疾病。世界卫生组织 2022 年 2 月发布的数据表明，每年约有 40 万名儿童患有癌症，最常见的类型因国家而异。例如，子宫颈癌是 23 个国家中最常见的癌症。全球癌症负担的增加也增加了癌症恶病质的盛行率，其特征是蛋白质和能量负平衡、全身性发炎和无意识的去脂体重损失。癌症恶病质和癌症的盛行率不断上升，以及新型癌症恶病质治疗研发投资的增加，是推动市场成长的主要因素。

癌症恶病质市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 5.90% 左右的复合年增长率成长

根据治疗细分，预计孕激素将在 2023 年显示最大的市场份额

基于动作细分机制，食慾刺激器是2023年的主导类型

按地区划分，北美是 2023 年的主要收入来源

癌症恶病质市场-細項分析：

全球癌症恶病质市场根据治疗、作用机制、应用和区域进行广泛细分。

根据治疗方法，市场分为四类：黄体素、皮质类固醇、合併疗法等。由于其成本较低且治疗癌症恶病质的效率较高，黄体素细分市场将在 2023 年占据主导市场。

依作用机制，市场大致分为两类：食慾刺激剂和减肥稳定剂。根据作用机制，食慾刺激剂预计将在癌症恶病质市场中占据主导地位并显着增长。癌症患者经常会出现食慾不振和体重意外减轻的情况，这与体能状态下降、对治疗的反应和耐受性降低、生存率降低以及生活品质下降有关。因此，对于食慾下降的患者，越来越多地考虑使用食慾兴奋剂。癌症恶病质盛行率的上升是推动市场成长的主要因素。

癌症恶病质市场 - 地理洞察

从地理来看，这个市场遍及欧洲、北美、拉丁美洲、亚太地区以及中东和非洲。这些区域根据参与国家进一步细分。由于癌症和癌症恶病质的高负担、众多药品製造商的存在以及癌症患者护理的进步，预计北美将引领市场。根据 GLOBOCAN 2020 估计，墨西哥报告了约 195,499 例新癌症病例。此外，美国癌症协会预计 2022 年美国将诊断出约 190 万例新癌症病例。

癌症恶病质市场-竞争格局：

癌症恶病质市场得到整合，只有少数几家大公司在全球和地区开展业务。这些关键参与者主要专注于研发，开发治疗癌症恶病质的高效新药，导致越来越多的治疗药物等待批准和商业上市。截至 2022 年 10 月，clinicaltrials.gov 报告了 150 项已进行或正在进行的研究，旨在开发治疗癌症恶病质的药物。例如，2020 年 12 月，哥本哈根大学与纽西兰大学医院合作发起了一项研究，监测医用大麻二酚对接受奥沙利铂或紫杉醇化疗的患者去脂体重（恶病质）的影响。

最近的发展：

2021 年1 月，Helsinn 集团和小野製药有限公司在日本获得批准生产和销售Adlumiz，这是一种生长素释放肽受体激动剂，用于治疗非小细胞肺癌、胃癌、胰腺癌或大肠癌患者的癌症恶病质。因此，该领域研发活动的增加预计将推动市场成长。

目录

第 1 章：癌症恶病质市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • Therapeutics 癌症恶病质市场片段
    • 癌症恶病质市场片段（依作用机转）
    • 癌症恶病质市场片段（依应用）
    • 按国家/地区分類的癌症恶病质市场片段
    • 按地区分類的癌症恶病质市场片段
  • 竞争洞察

第 3 章：癌症恶病质主要市场趋势

  • 癌症恶病质市场驱动因素
    • 市场驱动因素的影响分析
  • 癌症恶病质市场限制
    • 市场限制影响分析
  • 癌症恶病质市场机会
  • 癌症恶病质市场未来趋势

第 4 章：癌症恶病质产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：癌症恶病质市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：癌症恶病质市场格局

  • 2023 年癌症恶病质市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：癌症恶病质市场 - 依治疗方法

  • 概述
    • 按治疗方法分類的细分市场占有率分析
    • 黄体素
    • 皮质类固醇
    • 联合疗法
    • 其他治疗

第 8 章：癌症恶病质市场 - 依作用机制

  • 概述
    • 按作用机制分類的细分市场占有率分析
    • 食慾刺激器
    • 减肥稳定剂

第 9 章：癌症恶病质市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 医院药房
    • 零售药房
    • 网路药房

第 10 章：癌症恶病质市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美癌症恶病质主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按治疗方法）
    • 北美市场规模与预测（按作用机制）
    • 北美市场规模和预测（按应用）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲癌症恶病质主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按治疗方法）
    • 欧洲市场规模与预测（按作用机制）
    • 欧洲市场规模和预测（按应用）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区癌症恶病质主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模和预测（按治疗方法）
    • 亚太地区市场规模与预测（按作用机制）
    • 亚太地区市场规模与预测（按应用）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲癌症恶病质主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按治疗方法）
    • 拉丁美洲市场规模与预测（按作用机制）
    • 拉丁美洲市场规模与预测（按应用）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲癌症恶病质主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按治疗方法）
    • 中东和非洲市场规模和预测（按作用机制）
    • 中东和非洲市场规模及预测（按应用）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 癌症恶病质产业

  • 竞争仪表板
  • 公司简介
    • Aeterna Zentaris
    • Aphios Corporation
    • Bristol-Myers Squibb Company
    • Pfizer Inc.
    • Helsinn Group
    • Merck KGaA
    • Artelo Biosciences Inc.
    • NGM Biopharmaceuticals
    • Aveo Oncology
    • Aavogen Inc.
    • Green Cross Wellbeing Corporation
    • Cannabics Pharmaceuticals Inc.
    • TCI Peptide Therapeutics
    • Fresenius Kabi
    • Tetra Bio-Pharma
    • Actimed Therapeutics
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV3357

REPORT HIGHLIGHT

Cancer Cachexia Market size was valued at USD 3,228.32 Million in 2023, expanding at a CAGR of 5.90% from 2024 to 2032.

Cancer cachexia presents as a multifaceted metabolic syndrome frequently observed in patients with advanced stages of malignancy. Characterized by involuntary weight loss, skeletal muscle wasting, fatigue, and anorexia, this syndrome transcends the limitations of inadequate dietary intake. Underlying mechanisms encompass systemic inflammation, metabolic aberrations, and the host's response to tumor-derived factors. Despite advancements in oncological therapies, cancer cachexia remains a formidable challenge, significantly impacting both the treatment outcomes and quality of life for affected individuals.

Cancer Cachexia Market- Market Dynamics

Rising cancer burden to propel market demand

The global cancer burden is rising, necessitating the modification of cancer therapies according to national and regional priorities. According to the (IARC) International Agency for Research on Cancer in December 2020, 1 in 5 people globally will develop cancer during their lifetime, with 1 in 11 women and 1 in 8 men dying from the disease. Data from the WHO, published in February 2022, indicates that approximately 400,000 children develop cancer annually, with the most common types varying by country. For instance, cervical cancer is the most prevalent in 23 countries. The increasing global cancer burden also raises the prevalence of cancer cachexia, characterized by negative protein and energy balance, systemic inflammation, and involuntary loss of lean body mass. The growing prevalence of cancer cachexia, and cancer along with increased investment in R&D for novel cancer cachexia treatments, are major factors driving market growth.

Cancer Cachexia Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.90% over the forecast period (2024-2032)

Based on Therapeutics segmentation, progestogens were predicted to show maximum market share in the year 2023

Based on the mechanism of action segmentation, appetite stimulators were the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Cancer Cachexia Market- Segmentation Analysis:

The Global Cancer Cachexia Market is broadly segmented on the basis of Therapeutics, Mechanism of Action, Application, and Region.

The market is divided into four categories based on Therapeutics: progestogens, corticosteroids, combination therapies, and others. The progestogens segment held a dominant market share in 2023, due to their lower cost and high efficiency in treating cancer cachexia.

The market is broadly divided into two categories based on mechanism of action: Appetite Stimulators and Weight Loss Stabilizers. By mechanism of action, appetite stimulators are expected to dominate and grow significantly in the cancer cachexia market. Cancer patients often experience sort of appetite loss and unintended weight loss, which are linked to decreased performance status, reduced response and tolerance to treatment, decreased survival, and diminished quality of life. Therefore, the use of appetite stimulants is increasingly considered for patients with reduced appetite. The rising prevalence of cancer cachexia is a major factor driving the market's growth.

Cancer Cachexia Market- Geographical Insights

From a geographical perspective, this market extends across Europe, North America, Latin America, Asia Pacific, and the Middle East and Africa. These regions are further segmented based on the participating nations. North America is expected to lead the market, driven by the high burden of cancer and cancer cachexia, the presence of numerous drug manufacturers, and advancements in cancer patient care. According to GLOBOCAN 2020 estimates, Mexico reported around 195,499 new cancer cases. Additionally, the American Cancer Society projected approximately 1.9 million new cancer cases would be diagnosed in the United States in 2022.

Cancer Cachexia Market- Competitive Landscape:

The cancer cachexia market is consolidated, with only a few major companies operating globally and regionally. These key players are primarily focused on R&D to develop highly effective novel drugs for treating cancer cachexia, resulting in a growing pipeline of therapeutics awaiting approval and commercial launch. As of October 2022, clinicaltrials.gov reported 150 studies either conducted or ongoing to develop drugs for cancer cachexia. For instance, in December 2020, the University of Copenhagen, in collaboration with Zealand University Hospital, initiated a study to monitor the effect of the medical cannabidiol on the lean body mass (cachexia) in patients receiving Oxaliplatin- or Paclitaxel-based chemotherapy.

Recent Developments:

In January 2021, Helsinn Group and Ono Pharmaceutical Co. Ltd received approval in Japan to manufacture and market Adlumiz, a ghrelin receptor agonist for treating cancer cachexia in the patients with non-small cell lung cancer, gastric cancer, pancreatic cancer, or colorectal cancer. Therefore, increasing research and development activities in the field are expected to drive market growth.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CANCER CACHEXIA MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT

Aeterna Zentaris

Aphios Corporation

Bristol-Myers Squibb Company

Pfizer Inc.

Helsinn Group

Merck KGaA

Artelo Biosciences Inc.

NGM Biopharmaceuticals

Aveo Oncology

Aavogen Inc.

Green Cross Wellbeing Corporation

Cannabics Pharmaceuticals Inc.

TCI Peptide Therapeutics

Fresenius Kabi

Tetra Bio-Pharma

Actimed Therapeutics

Others

GLOBAL CANCER CACHEXIA MARKET, BY THERAPEUTICS - MARKET ANALYSIS, 2019 - 2032

  • Progestogens
  • Corticosteroids
  • Combination Therapy
  • Other Therapeutics

GLOBAL CANCER CACHEXIA MARKET, BY MECHANISM OF ACTION- MARKET ANALYSIS, 2019 - 2032

  • Appetite Stimulators
  • Weight Loss Stabilizers

GLOBAL CANCER CACHEXIA MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

GLOBAL CANCER CACHEXIA MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cancer Cachexia Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cancer Cachexia Market Snippet by Therapeutics
    • 2.1.2. Cancer Cachexia Market Snippet by Mechanism of Action
    • 2.1.3. Cancer Cachexia Market Snippet by Application
    • 2.1.4. Cancer Cachexia Market Snippet by Country
    • 2.1.5. Cancer Cachexia Market Snippet by Region
  • 2.2. Competitive Insights

3. Cancer Cachexia Key Market Trends

  • 3.1. Cancer Cachexia Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cancer Cachexia Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cancer Cachexia Market Opportunities
  • 3.4. Cancer Cachexia Market Future Trends

4. Cancer Cachexia Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cancer Cachexia Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Cancer Cachexia Market Landscape

  • 6.1. Cancer Cachexia Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cancer Cachexia Market - By Therapeutics

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Therapeutics, 2023 & 2032 (%)
    • 7.1.2. Progestogens
    • 7.1.3. Corticosteroids
    • 7.1.4. Combination Therapy
    • 7.1.5. Other Therapeutics

8. Cancer Cachexia Market - By Mechanism of Action

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Mechanism of Action, 2023 & 2032 (%)
    • 8.1.2. Appetite Stimulators
    • 8.1.3. Weight Loss Stabilizers

9. Cancer Cachexia Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2. Hospital Pharmacy
    • 9.1.3. Retail Pharmacy
    • 9.1.4. Online Pharmacy

10. Cancer Cachexia Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Cancer Cachexia Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Cancer Cachexia Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Cancer Cachexia Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Cancer Cachexia Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Cancer Cachexia Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Cancer Cachexia Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Aeterna Zentaris
    • 11.2.2. Aphios Corporation
    • 11.2.3. Bristol-Myers Squibb Company
    • 11.2.4. Pfizer Inc.
    • 11.2.5. Helsinn Group
    • 11.2.6. Merck KGaA
    • 11.2.7. Artelo Biosciences Inc.
    • 11.2.8. NGM Biopharmaceuticals
    • 11.2.9. Aveo Oncology
    • 11.2.10. Aavogen Inc.
    • 11.2.11. Green Cross Wellbeing Corporation
    • 11.2.12. Cannabics Pharmaceuticals Inc.
    • 11.2.13. TCI Peptide Therapeutics
    • 11.2.14. Fresenius Kabi
    • 11.2.15. Tetra Bio-Pharma
    • 11.2.16. Actimed Therapeutics
    • 11.2.17. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Cancer Cachexia Market: Therapeutics Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Therapeutics
  • TABLE Global Cancer Cachexia Market, by Therapeutics 2019-2032 (USD Million)
  • TABLE Cancer Cachexia Market: Mechanism of Action Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Mechanism of Action
  • TABLE Global Cancer Cachexia Market, by Mechanism of Action 2019-2032 (USD Million)
  • TABLE Cancer Cachexia Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Cancer Cachexia Market, by Application 2019-2032 (USD Million)
  • TABLE Cancer Cachexia Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Cancer Cachexia Market, by Region 2019-2032 (USD Million)
  • TABLE North America Cancer Cachexia Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Million)
  • TABLE North America Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Million)
  • TABLE North America Cancer Cachexia Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Cancer Cachexia Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Million)
  • TABLE Europe Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Million)
  • TABLE Europe Cancer Cachexia Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Cancer Cachexia Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Million)
  • TABLE Asia Pacific Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Million)
  • TABLE Asia Pacific Cancer Cachexia Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Cancer Cachexia Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Million)
  • TABLE Latin America Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Million)
  • TABLE Latin America Cancer Cachexia Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Cancer Cachexia Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Cancer Cachexia Market, by Application, 2019-2032 (USD Million)

List of Figures

  • FIGURE Cancer Cachexia Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Therapeutics segment market share analysis, 2023 & 2032
  • FIGURE Therapeutics segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mechanism of Action segment market share analysis, 2023 & 2032
  • FIGURE Mechanism of Action segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Cancer Cachexia Market share and leading players, 2023
  • FIGURE Europe Cancer Cachexia Market share and leading players, 2023
  • FIGURE Asia Pacific Cancer Cachexia Market share and leading players, 2023
  • FIGURE Latin America Cancer Cachexia Market share and leading players, 2023
  • FIGURE Middle East and Africa Cancer Cachexia Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Cancer Cachexia Market share analysis by country, 2023
  • FIGURE Germany Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Cancer Cachexia Market share analysis by country, 2023
  • FIGURE India Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Cancer Cachexia Market share analysis by country, 2023
  • FIGURE Brazil Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Cancer Cachexia Market share analysis by country, 2023
  • FIGURE Saudi Arabia Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)